Diagnostics, Executive Summary

At $24.9 billion in revenues, the Diagnostics industry is projected to deliver another year of double-digit growth, following an 11% gain (in actual dollars) in 2003. Several factors contribute to its well-being, favorable currency exchange rates, continuing growth in molecular testing (NAT) and glucose monitoring (combined these account for 27% of industry sales), and worsening labor shortages that spur demand for lab automation and work-cell consolidation.